Multiple System Atrophy Clinical Trials in Boston, Massachusetts

4 studies are recruiting for multiple system atrophy in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

    The primary objective of the study is to evaluate the efficacy of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the study is to evaluate specific efficacy parameters of TEV-56286. Another secondary objective is to …

    Stage
    Phase 2
    Ages
    30 to 75
    Site
    Teva Investigational Site 15736, Boston, Massachusetts
    Locations
    61 in total
    Run by
    Teva Branded Pharmaceutical Products R&D LLC

    See if you can join NCT06568237 on ClinicalTrials.gov

  2. Natural History Study of Synucleinopathies

    Synucleinopathies are a group of rare diseases associated with worsening neurological deficits and the abnormal accumulation of the protein α-synuclein in the nervous system. Onset is usually in late adulthood at age 50 or older. Usually, synucleinopathies present clinically with slowness of moveme…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Beth Israel Deaconess Medical Center, Boston, Massachusetts
    Locations
    8 in total
    Run by
    NYU Langone Health

    See if you can join NCT01799915 on ClinicalTrials.gov

  3. A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

    A Phase 2a Study of Foralumab Nasal in Patients with Multiple System Atrophy (MSA)

    Stage
    Phase 2
    Ages
    30 to 85
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Run by
    Tiziana Life Sciences LTD

    See if you can join NCT06868628 on ClinicalTrials.gov

  4. The CurePSP Genetics Program

    This study is an observational, prospective genetic study. It aims to obtain DNA for research and testing from patients with PSP, CBS, MSA, and related neurological conditions and their families. Up to 1,000 adults who have been clinically diagnosed with PSP, CBS, MSA, or related neurological condi…

    Stage
    Not phased
    Ages
    35 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Massachusetts General Hospital

    See if you can join NCT06647641 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.